Recall Register

Device recall: t:slim X2 Insulin Pump with Interoperable Technology

Class I FDA enforcement event 96417. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

A software defect in Version 7.9 of the pump software for Tandem t:slim X2 and Tandem Mobi pumps, when used with Control IQ+ technology, will cause the pump to incorrectly interpolate glucose trends when the Estimated Glucose Value (EGV) is above 255 mg/dL at the start or end of a gap in data collection due to a lapse in connection from a paired continuous glucose monitor (CGM) sensor, which can…

Class I, in the words of FDA

a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death

Tandem Diabetes Care, Inc. started this device recall on 27 Feb 2025. The firm address in the FDA record is in San Diego, CA. FDA put the recall in Class I. FDA event 96417 has 2 product records. The first FDA enforcement report date is 23 Apr 2025. The record gives the status Ongoing. 219 of the 945 device events that started in 2025 have more product records. The median device event of 2025 has 1 product record. The openFDA file has 945 device events that started in 2025 and 972 that started in 2024.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

US: AZ, CA, CO, CT, FL, HI, IA, ID, IL, IN, MD, ME, MI, MO, MS, NC, ND, NE, NJ, NM, NV, NY, OH, PA, TX, UT, VA, WA, WI OUS: N/A

Recalling firm

Tandem Diabetes Care, Inc., San Diego, CA.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

2 product records in the event.

FDA event 96417: product records
Recall numberProductQuantityClassStatusReport date
Z-1519-2025t:slim X2 Insulin Pump with Interoperable Technology63 unitsClass IOngoing23 Apr 2025
Z-1520-2025Tandem Mobi Insulin Pump with Interoperable Technology85 unitsClass IOngoing23 Apr 2025

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class I: The highest of the three FDA recall classes.

The event in context

Device events that started in 2025
945
Share of these events in Class I
13%
Product records in this event
2Median of the firm: 1
Events of the firm on the register
12

Other events of the firm

Other FDA enforcement events of Tandem Diabetes Care, Inc.
InitiatedProduct (first record)TypeClassRecords
16 Jul 2026Brand Name: Tandem t:slim mobile application Product Name: t:slim Mobile Application, iOS Model/Catalog Number: iOS softDeviceClass II1
30 Jan 2026Tandem pumps are battery-operated infusion pumps capable of both basal and bolus delivery of insulin. The pumps utilize DeviceClass II1
6 Oct 2025Tandem Mobi Insulin Pump: Description/Catalog: Tandem insulin pumps are battery-operated infusion pumps capable of both DeviceClass I1
5 Aug 2025t:slim X2 insulin pump with Interoperable Technology, Control-IQ+ technology, REF: 1014070, 1014071, 1014072, 1014073, aDeviceClass II1
21 Jul 2025Battery Operated infusion pumps. t:slim X2 G5, Replacement, Refurbished, REF: 1000911; t:slim X2 GS Classic, ReplacementDeviceClass I1
3 Jul 2025t:slim X2 Insulin Pump with Interoperable Technology (with Tandem t:slim mobile app)DeviceClass II1
5 Mar 2024t:connect mobile app used in conjunction with t:slim X2 insulin pump with Control-IQ technologyDeviceClass I1
24 May 2022t:slim X2 insulin pump; t:slim X2 insulin pump with Dexcom G5; t:slim X2 insulin pump with Basal-IQ technology; t: slim DeviceClass II2
10 Sep 2020t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM, and t:slim X2 Insulin Pump with Basal-IQ TechnologyDeviceClass II1
23 Apr 2018t:slim G4 Insulin Pump with Dexcom G4 Platinum CGM Software version: 4.3.4.3, Firmware version: 004722, Firmware, Fuel GDeviceClass II1

Tandem Diabetes Care, Inc.: all 12 events

Official channels

Cite this page

Recall Register. FDA enforcement event 96417. https://recallregister.com/fda/i/96417/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: US: AZ, CA, CO, CT, FL, HI, IA, ID, IL, IN, MD, ME, MI, MO, MS, NC, ND, NE, NJ, NM, NV, NY, OH, PA, TX, UT, VA, WA, WI OUS: N/A
What quantity of product is in FDA event 96417?
The event has 2 product records. The first record gives this quantity: 63 units
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2025 have the same class?
13% of the 945 device events that started in 2025 are in Class I.